Welcome to MeTA
Medicines Transparency Alliance (MeTA) is a multi-stakeholder alliance working to improve access and affordability of medicines for the one-third of the world’s population unable to access essential medicines due to high cost or local unavailability.
The Benefits of MeTA:
- Promotes transparency
- Generates accountability
- Increases collaboration
- Encourages equity
- Improves efficiency
- Advocates for access to medicines
Action from the grassroots to parliament
Access to essential medicines gets an airing in Zambia
WHO assessment tool for measuring transparency in the public pharmaceutical sector
A tool to measure the level of transparency and vulnerability to corruption in selected areas of the public pharmaceutical sector, developed under...
Survey of the quality of selected antimalarial medicines circulating in Madagascar, Senegal, and...
First findings from a study by WHO and the Drug Quality and Information Program on the quality of key antimalarial medicines in Sub-Saharan African...
The role of local manufacturers in improving access to essential medicines: the case of Uganda
Facing the challenges that threaten the growth of local industry is not an easy task
Lower taxes to improve access to medicines
Does taxing essential medicines hinder access to treatment?
- Prices
The most effective medicines in the world are useless if they are priced too high - Quality
When you take your pill, you want to be sure that it is of good quality - Availability
One in every three people in the world does not have the basic medicines they need - Promotion
Medicines' promotion to agencies, professionals and users should adhere to strict ethical standards - Transparency & accountability
Information is power – if it is acted on - Multi-stakeholder working
Bringing together the people and organisations that can make change, that can be held to account and hold others to account
Action from the grassroots to parliament
Access to essential medicines gets an airing in Zambia
WHO assessment tool for measuring transparency in the public pharmaceutical sector
A tool to measure the level of transparency and vulnerability to corruption in selected areas of the public pharmaceutical sector, developed under...
Survey of the quality of selected antimalarial medicines circulating in Madagascar, Senegal, and...
First findings from a study by WHO and the Drug Quality and Information Program on the quality of key antimalarial medicines in Sub-Saharan African...
The role of local manufacturers in improving access to essential medicines: the case of Uganda
Facing the challenges that threaten the growth of local industry is not an easy task